Lightnews — Scholar-powered news

Reposted by UCLA Pathology

Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · 5d

Bx for new onset NS in an older adult. Serologic work up including SPEP/UPEP IFE negative. Bx shows membranous pattern with few double contours. IgG3-k restriction and mottle EM deposits c/w PGNMID with membranous predominant pattern. PLA2R- #renalpath #pathsky #nephsky

1 3 8

Reposted by UCLA Pathology

Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · 2d

A startling biopsy. Severe acute TMA in a pt with suspected scleroderma renal crisis. Massive vascular thrombosis, mucoid intimal edema, and early onion skin change associated with severe cortical necrosis. #renalpath #nephsky #pathsky

1 7 17

Reposted by UCLA Pathology

Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · 3d

Bx for nephrotic syndrome in an IV drug user with multiple infections. LM was all medulla, but good enough to make a diagnosis. AA amyloidosis; very common bx result in this clinical setting. #renalpath #pathsky #nephsky

1 7

UCLA Pathology @uclapathology.bsky.social · 3d

📢 UCLA is in the race to win the #WeGiveBloodDrive — a Big Ten-wide challenge powered by Abbott to inspire blood donations & save lives.

💪Donate Now-Dec 5
🏆 Help UCLA win a $1 MILLION prize 💰 for student & community health!
🩸 Save Lives!

Learn More ➨ bit.ly/4o6CVKp

UCLA Pathology @uclapathology.bsky.social · 4d

In his free time, David enjoys soccer, tennis, and reading. His current favorite LA restaurant is Holbox.

David’s pathology interests are in Neuropathology. We’re excited to have him on our team and look forward to seeing all he accomplishes.

Welcome to UCLA Pathology, David! #PathSky

1

UCLA Pathology @uclapathology.bsky.social · 4d

💫 First Year Feature Monday 💫

Meet UCLA Pathology's David Lauzier, MD! David is a first year AP/NP resident from Hickory, NC. He completed his undergraduate studies at University of North Carolina and earned his medical degree from Washington University in St. Louis.

1 1

Reposted by UCLA Pathology

Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · 6d

Kidney txp biopsy for AKI (~6 post txp). Tubular injury associated with granular and ropey trichome positive casts. IHC confirmed myoglobin cast nephropathy. CK found to be very high; thought to be due to statin related myopathy. #renalpath #pathsky #nephsky

4 6

UCLA Pathology @uclapathology.bsky.social · 8d

💫 We invite you to read & reflect on Dr. Sarah Dry’s October Chair Message. It features Quality Improvement and Lab Stewardship updates along with department events and news. #pathology #path2path #PathSky #QualityImprovement #LabStewardship

Read More ➨ bit.ly/3VILqiO

2

UCLA Pathology @uclapathology.bsky.social · 10d

Cast your vote today and help us champion a changemaker who’s shaping the future of Pathology. Let’s make Dr. Lilley the standout favorite in his category!

Cast Your Vote ➨ ow.ly/CaG650X0TGu

#pathology #path2path #PathSky #risingstar #PowerList2025 #LeadingVoices

1

UCLA Pathology @uclapathology.bsky.social · 10d

🏅 We’re thrilled to announce Dr. Cullen Lilley (@clilleymd.bsky.social) has been officially named to the 2025 Power List by The Pathologist’s Magazine — a prestigious honor recognizing the most visionary and impactful young leaders in Pathology and Laboratory Medicine!

1 1 1

UCLA Pathology @uclapathology.bsky.social · 15d

💫 We are proud to recognize our outstanding Trainees who represented UCLA Pathology at the College of American Pathologists (CAP) meeting in Orlando!

#CAP25 #CAP2025 #PathologyResearch #ResidentLife #PosterPresentations #PathMatch #Pathology #path2path #PathSky @pathologists.bsky.social

1 3

Reposted by UCLA Pathology

Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · 23d

Heavy Chains, Heavy Consequences: A Case of Concomitant Heavy Chain Amyloidosis and Heavy Chain Deposition Disease. Fibrils and powdery deposits. #renalpath #nephsky #pathsky www.sciencedirect.com/science/arti...

1 5 7

UCLA Pathology @uclapathology.bsky.social · 18d

Congratulations to UCLA Pathology's Employee of the Month, Chen! 🎉 #pathology #path2path #PathSky

1

UCLA Pathology @uclapathology.bsky.social · 22d

🔬UCLA Pathology's Post-Sophomore/Junior Fellowship Program is now recruiting medical students to join our 1-Year #Pathology Fellowship for 2026-2027! #PathSky #path2path #pathfellowship @dgsomucla.bsky.social

Apply today! 👉 bit.ly/4mexWqi

2

UCLA Pathology @uclapathology.bsky.social · 23d

🔬 We are now recruiting a Renal Pathologist! #pathology #path2path #PathSky #renalpath

Join our team today! ➨ bit.ly/46CqsrU

1 2

Reposted by UCLA Pathology

Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · 29d

Multiple diagnoses not uncommon in kidney biopsies. This case showed nodular diabetic nephropathy, a mostly chronic ANCA associated GN, and to top it off some interstitial ALECT2 amyloidosis. #renalpath #nephsky #pathsky

2 5 11

UCLA Pathology @uclapathology.bsky.social · 25d

💫 Our Clinical Chemistry Fellowship is now accepting applications! #pathology #path2path #PathX #Fellowship #ClinChem ⚗️🧪

Apply Now! 👉 bit.ly/46J8pko
Learn More 👉 bit.ly/46yMmu7

Reposted by UCLA Pathology

Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · Sep 8

Lupus nephritis case with prominent podocyte cytoplasmic vacuolization on LM with myelin figures revealed by EM. Probably HCQ effect but given its prominence genetic etiologies should be excluded (e.g., Fabry, LMX1B). #renalpath #pathsky #nephsky

1 6 12

UCLA Pathology @uclapathology.bsky.social · 28d

🔬 We are now recruiting a Faculty Clinical Pathologist, Hematology and Coagulation! #pathology #path2path #PathSky #Hematology #Coagulation

Join our team today! ➨ bit.ly/46eO7xd

UCLA Pathology @uclapathology.bsky.social · 29d

Chagas disease is now considered endemic in parts of the U.S. & UCLA Pathology's Dr. Shaun Yang is helping raise awareness. As a clinical microbiologist, he shares insights on how this often-overlooked illness spreads & why early detection matters. #ClinMicro

www.uclahealth.org/news/article...

Chagas disease, which can be deadly, is now considered endemic in the U.S.

www.uclahealth.org

1 2

UCLA Pathology @uclapathology.bsky.social · Sep 10

🏅 Dr. Imir Metushi is a 2025 ASCP 40 Under Forty honoree—let’s get him to the Top Five! From UCLA’s Olympic Lab to global mentorship, he’s advancing Pathology and Clinical Chemistry.

🗳️ Vote by Sept 12 👉 bit.ly/4n74YJl

#ASCP40UnderForty #UCLA #PathSky #ClinicalChemistry #Pathology #Path2Path

UCLA Pathology @uclapathology.bsky.social · Sep 9

🎙️ Join us for Grand Rounds on Fri 9/12 at 12:00 PM PT featuring Dr. Loren Gragert (@lorengragert.bsky.social) presenting on "Immune Compatibility Factors in US Kidney Allocation Policy."

Full schedule here ➨ bit.ly/3BMx0E3

#Pathology #Path2Path #PathSky #renalpath

1

UCLA Pathology @uclapathology.bsky.social · Sep 7

🎙️ Join us for our upcoming Pathology Grand Rounds events! #Pathology #path2path #PathSky #GrandRounds #MedEd

2025-2026 Schedule ➨ bit.ly/3PYDnwG

Reposted by UCLA Pathology

Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · Sep 4

Interesting case of AL-amyloidosis. Massive vascular deposits, even in hilar arterioles with glomerular sparring. Patient had minimal proteinuria given lack of glomerular amyloid. #renalpath #pathsky #nephsky

2 4 12

UCLA Pathology @uclapathology.bsky.social · Sep 4

🏅 Congrats to Dr. Imir Metushi—2025 ASCP 40 Under Forty honoree! From leading UCLA’s Olympic Analytical Lab to mentoring global lab leaders, he’s redefining the future of Pathology. #ASCP40UnderForty #PathSky

🗳️ Want to help him reach the Top Five?
👉 Cast Your Vote: bit.ly/4n74YJl